Skip to main contentSkip to navigation
Sirius Investors

DSNKY Stock: Daiichi Sankyo Company, Limited Stock Price, Analysis & Insights

Get live DSNKY stock price $15.42, comprehensive Daiichi Sankyo Company, Limited stock analysis, charts, news, and expert forecast. Real-time DSNKY stock data and investment insights.

15.42
3.20%Today
DSNKYDaiichi Sankyo Company, Limited • Other OTC • Healthcare
Market Cap
28.06B
Volume
11.26K
52W High
27.50
52W Low
14.98

Loading chart data...

Daiichi Sankyo Company, Limited (DSNKY) Overview

Daiichi Sankyo Company, Limited (DSNKY) is a publicly traded company in the Healthcare sector , specifically within the Drug Manufacturers - General industry . As of the latest trading session, DSNKY trades at $15.42 with a market capitalization of 28.06B . Over the past 52 weeks, DSNKY has traded between $14.98 and $27.50 , with the current price positioned at approximately 4% of this range . ...

Key Takeaways

  • Operates in the Healthcare sector (Drug Manufacturers - General)
  • Market cap: 28.06B
  • Current price: $15.42
  • 52-week range: $14.98 - $27.50
  • P/E ratio: 17.52

Investment Score

Annual (latest period)
Unavailable

A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Daiichi Sankyo Company, Limited is a global pharmaceutical enterprise that encompasses the entire lifecycle of drug development, from pioneering research and development to manufacturing, importation, marketing, and worldwide distribution of its medi...

Company Information

CEO
Hiroyuki Okuzawa
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
18726

Contact Information

Address
3-5-1, Nihonbashi-honcho
Country
JP

Investment Analysis & Business Insights

Healthcare
Drug Manufacturers - General

Investment Highlights

Strong presence in the Healthcare sector with established market position

Valuation metrics suggest potential value opportunity (P/E: 17.5)

Lower volatility stock (Beta: -0.15) may provide portfolio stability

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for Daiichi Sankyo Company, Limited shareholders
  • Market volatility can significantly impact stock price, especially for mid-cap stocks
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for Daiichi Sankyo Company, Limited
  • Investors should consider how Daiichi Sankyo Company, Limited fits within their overall portfolio allocation

Market Cap

28.06B

P/E Ratio (TTM)

17.52

Beta

-0.15

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.